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ABSTRACT
Telomere shortening has emerged as an important biomarker of aging. Longitudinal
studies consistently find that, although telomere length shortens over time on average,
there is a subset of individuals for whom telomere length is observed to increase. This
apparent lengthening could either be a genuine biological phenomenon, or simply
due to measurement and sampling error. Simons, Stulp & Nakagawa (2014) recently
proposed a statistical test for detecting when the amount of apparent lengthening in a
dataset exceeds that which should be expected due to error, and thus indicating that
genuine elongation may be operative in some individuals. However, the test is based on
a restrictive assumption, namely that each individual’s true rate of telomere change is
constant over time. It is not currently known whether this assumption is true. Here we
show, using simulated datasets, thatwith perfectmeasurement and large sample size, the
test has high power to detect true lengthening as long as the true rate of change is either
constant, or moderately stable, over time. If the true rate of change varies randomly
from year to year, the test systematically returns type-II errors (false negatives; that
is, failures to detect lengthening even when a substantial fraction of the population
truly lengthens each year). We also consider the impact of measurement error. Using
estimates of the magnitude of annual attrition and of measurement error derived from
the human telomere literature, we show that power of the test is likely to be low in
several empirically-realistic scenarios, even in large samples. Thus, whilst a significant
result of the proposed test is likely to indicate that true lengthening is present in a data
set, type-II errors are a likely outcome, either ifmeasurement error is substantial, and/or
the true rate of telomere change varies substantially over time within individuals.
Subjects Genetics, Genomics, Epidemiology, Statistics
Keywords Telomere length, Biomarkers, Statistics, Telomere lengthening, Aging
INTRODUCTION
Telomere shortening in tissues such as blood has emerged as an important biomarker of
ageing (Müezzinler, Karina & Brenner, 2013), predictor of future morbidity and mortality
(Heidinger et al., 2012; Boonekamp et al., 2013; Rode, Nordestgaard & Bojesen, 2015), and
indicator of accumulated adversity (Hau et al., 2015; Bateson, 2016). Telomeres are
repetitive DNA sequences at the end of eukaryotic chromosomes that, on average at
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the population level, shorten with age. In longitudinal studies, though, there is often a
substantial fraction of the sample that shows an increase in measured telomere length
(Steenstrup et al., 2013b; Simons, Stulp & Nakagawa, 2014). The observation of apparent
lengthening is potentially important, since it points to the possibility that a marker of
cellular ageing might under some circumstances be reversible in vivo. However, telomere
length cannot be measured with perfect precision. There is error variation both due to
sampling (heterogeneity in cells within an individual lead to variable estimates of that
individual’s average telomere length), and measurement (laboratory assays do not produce
identical results each time even with the same sample). The existence of error variation
means that the second of two longitudinal samples may show a higher value than the first
even if the true average telomere length has not increased. Thus, it is possible that apparent
telomere lengthening in a sample represents no more than error (Steenstrup et al., 2013b;
Bateson & Nettle, 2017).
Simons, Stulp & Nakagawa (2014) recently proposed a statistical test for detecting when
there is more observed lengthening in a longitudinal sample than should be expected under
the hypothesis of error alone, and hence for inferring when true lengthening is likely to be
present in some subset of the sample. This is potentially a useful innovation as it might allow
resolution of whether apparent telomere lengthening over time in vivo is a biologically
real phenomenon or not. The test requires that each individual is measured at three or
more time points. To complete the test, a ratio of two variance estimators (henceforth,
the F-ratio) is compared to an F-distribution, in a similar manner to the F-test familiar
from ANOVA. Under the null hypothesis (no true lengthening), the two estimators will
be similar, the F-ratio will be close to 1, and the p-value from comparing the statistic to
the F-distribution with appropriate degrees of freedom will be large (i.e., not significant).
Under the alternative hypothesis (true lengthening is present), the numerator will be
substantially larger than the denominator, the F-ratio will be larger than 1, and the p-value
will therefore be small (considered significant by the usual convention when p< 0.05).
The numerator of the F-ratio estimates the variability in the sample by a calculation
based on the number of individuals who have a highermeasured telomere length at the final
time point compared to the first, and the magnitude of their apparent increase (Simons,
Stulp & Nakagawa (2014), Eq. (5); see Simons, Stulp & Nakagawa (2014), Appendix for
derivation of this estimator). The denominator of the F-ratio estimates what under the
null hypothesis is the same variability, in a different way. It fits a separate regression line
through the points corresponding to the repeat measurements of each individual (so the
number of regression lines is equal to the number of individuals in the sample). For each
of these lines, it calculates the variance of the residuals, the deviations of the points from
the fitted line. This is why three measurement points are required: with just two points, the
line goes through both and there is no residual. Finally, the variability of the whole sample
is estimated as the mean of the residual variance from each of the separate individual
regressions (see Simons, Stulp & Nakagawa (2014), Eqs. (1)–(3)).
There is an important assumption involved in the specification of the denominator of
the F-ratio statistic, namely that each individual’s telomeres truly change at a constant rate
over time. Thus, any deviation of the individual’s successive measurement points from
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a straight line (either going up, going down, or flat) can be taken to represent sampling
or measurement error. However, it is not currently known whether this assumption is
empirically plausible or not. The pace of telomere shortening has been linked to infection
(Asghar et al., 2015), adverse life events and stress (Epel et al., 2004; Puterman et al., 2014),
and health behaviours (Puterman et al., 2014). All of these factors are episodic or changeable
over time, so it could be that individuals’ telomeres change at different rates—or even in
different directions—in different years, without this being in any sense due tomeasurement
or sampling error. Two recent papers have specifically suggested that telomeres shorten in
a dynamic or oscillatory way, in which one year’s true attrition is not predictable from the
previous year’s (Svenson et al., 2011; Huzen et al., 2014).
If there are year-to-year changes in individuals’ rate of true shortening, then the linear
regressions for each individual would not fit perfectly, even if telomere length could be
measured with no error at all. The denominator of the F-ratio statistic proposed by Simons,
Stulp & Nakagawa (2014) thus actually sums together two components: the variability over
time of the true rate of telomere change within individuals, plus the measurement and
sampling error. This means that, where there is any variability in individual shortening
rates over time, the denominator of the test will be larger than it should be for the purposes
required of it, the F-ratiowill consequently be too small, and the test will potentially produce
a high rate of type-II errors (that is, false negatives, or failures to return a significant result
when a substantial proportion of the population do exhibit true lengthening each year).
It is common for statistical tests to rely in their derivation on assumptions that are not
exactlymet in real phenomena, but yet the tests still turn out to be useful. Thus, the question
is, how large would departures from constant rates of true shortening have to be to cause
substantial problems of type-II error for the proposed test? This question interacts with the
extent of measurement error. Simons, Stulp & Nakagawa (2014) show in simulations that,
other things being equal, increasing the extent of measurement error reduces the power of
the proposed test. This may be particularly true if the constant-true-rate assumption is also
violated. Here, we simulated large longitudinal telomere datasets, systematically varying
the extent of measurement error (none, small, large), and the assumed underlying true
dynamics (constant true rate for individuals, no individual consistency in the true rate,
moderate individual consistency in the true rate). To maximise the relevance to empirical
applications of the test, we used reported values from the human telomere literature in
constructing our simulations. Our objective was to estimate the likely power of the test to
detect true lengthening when true lengthening is in fact present. We kept the sample size
in our simulated datasets at 10,000 individuals throughout, so as to be able to understand
the power of the test even as sample size becomes very large.
METHODS
Our simulations are based on a computational model described formally in the Appendix,
and explored more fully in Bateson & Nettle (2017). The R code to generate all the results
that follow is available as Supplemental Information 1. The model assumes that telomere
length is measured every year, and it can be iterated to give as many years of data as
required.
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In the first stage of the model, the true telomere lengths at each time point for
n= 10,000 individuals are generated. The baseline telomere lengths are drawn from a
normal distribution with mean 7,000 base pairs (bp) and standard deviation 700 bp. The
second year’s telomere lengths are generated by subtracting a normally distributed random
amount with mean 30 bp and standard deviation 50 bp. This means that although the
average telomere length shortens from baseline to the second year, some individuals truly
lengthen. For example, an individual whose attrition is one standard deviation from the
mean in the positive direction actually experiences lengthening of 20 bp. The values for the
means and standard deviations of baseline telomere length and attrition are representative
of the empirical human literature (Aviv et al., 2009; Chen et al., 2011; Kark et al., 2012;
Steenstrup et al., 2013a).
In each subsequent year, attrition is repeated, again with a mean of 30 bp and standard
deviation of 50 bp. Attrition in each successive year can be made to be correlated with
attrition in the previous year (each new year’s attrition values are generated from the last
using Eq. (5) of Appendix). The level of autocorrelation is controlled by a parameter r. In
the case where r = 1, the amount of telomere change, whether shortening or elongation, is
constant from year to year. Thus, the r = 1 case captures the assumption made by Simons,
Stulp & Nakagawa (2014) in the derivation of their statistic. Where r = 0, attrition is
completely independent from year to year; an individual with relative fast attrition in one
year is just as likely as any other to have slow attrition the next year. Here, we investigate
three values of r : r = 1, where Simons, Stulp & Nakagawa’s (2014) constant-rate assumption
holds; r = 0, where there is no individual consistency at all in the rate of telomere change;
and r = 0.5, where there is partial but not complete individual consistency in the rate of
change over time, and so Simons, Stulp & Nakagawa’s (2014) assumption may be useful as
an approximation.
In a second stage of the model, measurement error can be introduced by assuming
that measured telomere length at each time point is an independently generated random
sample from a normal distribution with the mean equal to the true telomere length. For
the standard deviation of this error distribution, we investigated three values: 0, i.e., no
measurement error; 140 bp; and 560 bp. The latter two values were chosen to be high and
low in the range of recent estimates of the magnitude of technical variation in telomere
measurement (98–665 bp; Martin-Ruiz et al., 2015; Bateson & Nettle, 2017). Note that
measurement error is implemented as a fixed standard deviation around the true length,
and not as a coefficient of variation as in our previous paper (Bateson & Nettle, 2017).
Recent evidence suggests that the assumption implicit in the construction of a coefficient
of variation (that measurement error is proportional to the telomere length measured) may
not hold for telomere measurement, at least when done by qPCR (Verhulst et al., 2015).
We used the model to generate one hundred datasets at each combination of: two
to eleven years of follow-up; autocorrelations of r = 1, r = 0.5 and r = 0; and the three
levels of measurement error. All of these datasets contained true telomere lengthening,
though the proportion of true lengtheners varied as functions of both length of follow-up
and autocorrelation (Bateson & Nettle, 2017). For each dataset, we calculated the F-ratio
statistic using the code provided by Simons, Stulp & Nakagawa (2014). We investigated, for
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each combination of years of follow-up and r : first, how many true lengtheners there were
in each dataset; and second, how many of the possible 100 F-ratio tests were significant by
the conventional criterion of p< 0.05.
RESULTS
In Fig. 1, the points and dashed lines show the proportion of times the F-ratio test proposed
by Simons, Stulp & Nakagawa (2014) produced a significant result, as a function of the
number of years of follow-up, and broken down by the autocorrelation of individuals’
annual true telomere attritions (r = 0, r = 0.5 or r = 1), and the level of assumed
measurement error (SDe= 0, SDe= 140, SDe= 560). The mean proportion of individuals
whose telomeres truly lengthen varies as a function of r and the length of follow-up; it is
shown as the solid line in each panel of Fig. 1. The grey area shading corresponds to regions
where more than 5% of individuals showed true telomere lengthening, and so it would be
desirable for the proposed test to return a significant result.
We first consider the case where there was no measurement error (Figs. 1A, 1D and
1G). Where Simons, Stulp & Nakagawa’s (2014) assumption of a constant true rate was
met (Fig. 1G), the test successfully returned a significant result for every dataset using
these large samples. The same was also true when the constant-true-rate assumption was
not exactly met, but there was moderate temporal consistency in the true rate (Fig. 1D).
However, when there was no individual consistency in the true rate of attrition (Fig. 1A),
the proposed test systematically returned type-II errors for follow-up periods of five years
or more, even with no measurement error.
The second column of Fig. 1 shows the case of measurement error equal to a standard
deviation of 140 bp. Here, the test had low power (under 0.25) when Simons, Stulp &
Nakagawa’s (2014) assumption of a constant true rate was met (Fig. 1H), even in these
samples of 10,000 individuals. Where the assumption was not met (Figs. 1B and 1E), the
test always returned a non-significant result. Finally, we considered measurement error
equal to a standard deviation of 560 bp (Figs. 1C, 1F and 1I). Here, the test always returned
a non-significant result, although substantial fractions of the population exhibited true
lengthening.
DISCUSSION
We considered the performance of the F-ratio test proposed by Simons, Stulp & Nakagawa
(2014) on simulated longitudinal datasets, under different scenarios for the nature of the
true telomere dynamics and the magnitude of measurement error, where there was a
non-zero and known proportion of true telomere lengtheners, and the sample size was
very large. Ideally the test should have been significant in all or the vast majority of cases,
particularly those where the proportion of true lengtheners was substantial. We found
that, whilst the test correctly detected lengthening under two of our nine scenarios, for
the remainder, it either always or usually returned a type-II error. That is, it led to the
acceptance of a null hypothesis (no true lengthening) that should have been be rejected.
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Figure 1 The mean proportion of individuals exhibiting true telomere lengthening (solid line), and
the proportion of times the F-ratio test proposed by Simons, Stulp & Nakagawa (2014) returned a sig-
nificant result (points and dashed lines), for different numbers of years of follow-up, split by values of
the autocorrelation parameter r (A, B, C: r = 0; D, E, F: r = 0.5; G, H, I: r = 1), and level of measure-
ment error (A, D, G: 0 bp; B, E, H: 140 bp; C, F, I: 560 bp). The first point is after two years of follow-up,
since this is the earliest point where the test statistic can be calculated (baseline plus two follow-up mea-
surements). The grey area shading covers regions where the proportion of the population exhibiting true
lengthening is greater than 5%. When r = 1, individuals have a constant rate of change over the whole
time period. When r = 0, an individual’s telomere change in one time period is independent of their
change in the previous period. r = 0.5 indicates moderate individual consistency in the rate of change. At
each combination of r,measurement error, and years of follow-up, 100 datasets each of 10,000 individuals
were simulated.
Our first conclusion is that measurement error at the levels that have been reported
in the human literature reduces the power of the proposed test to a low level. Under
our smaller and larger non-zero measurement-error scenarios, the test returned a non-
significant result almost all of the time. This was despite our using samples (10,000
individuals) that are at the upper end of the size range studied in practice by empiricists.
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The finding that increased measurement error reduces the test’s power accords with the
power simulations presented by Simons, Stulp & Nakagawa (2014). They found that power
was good as long as the standard deviation of true attrition was larger than the standard
deviation due to measurement error (see Simons, Stulp & Nakagawa (2014), Fig. 1). We
agree, but would argue that the standard deviation of attrition is generally much smaller
than the standard deviation due to measurement error in practice. For humans, the best
empirical estimates are that the standard deviation of annual true telomere attrition is of
the order 14–53 bp/year for humans (Aviv et al., 2009; Chen et al., 2011; Kark et al., 2012;
Steenstrup et al., 2013a), whilst the standard deviation due to measurement error is of the
order of 98–665 bp (Martin-Ruiz et al., 2015; Bateson & Nettle, 2017). Technical precision
may vary from technique to technique (Verhulst et al., 2015; Verhulst et al., 2016), and run-
ning extra technical replicates can reduce the magnitude of measurement error (Verhulst et
al., 2015; Eisenberg, 2016). Nonetheless, researchers using the test should be mindful that if
themagnitude of themeasurement error in their data is the same as or larger than themagni-
tude of the variation in true telomere attrition, the test will be prone to return type-II errors.
Our second conclusion concerns Simons, Stulp & Nakagawa’s (2014) assumption that
the true rate of telomere attrition is perfectly consistent within individuals over time.
Violations of this assumption also reduce the power of the test. In particular, the test
never once returned a significant result, in 4000 attempts, where the constant-true-rate
assumption was not true and there was anymeasurement error. Even with nomeasurement
error, the power of the test was very low at long follow-ups under the scenario of
no individual consistency in true attrition from year to year. These type-II errors are
understandable. When the true rate of attrition varies within individuals, the denominator
of the F-ratio is systematically too large, because it adds the variability in the annual rate of
true attrition to the calculation of the error variation. Thus, the F-ratio statistic is almost
always less than one, and a significant result can very rarely be generated. Thus, the Simons,
Stulp & Nakagawa (2014) approach to detecting telomere elongation would be problematic
if it turned out that the true rate of attrition varies substantially from year to year.
We do not currently know to what extent individuals’ true telomere losses are consistent
from year to year. Bateson & Nettle (2017) used observed patterns of apparent lengthening
in data sets with different durations of follow-up to estimate that individual consistency in
the rate of attrition is low. Two recent empirical studies have suggested that telomere change
tends to oscillate, with periods of rapid attrition followed by periods of elongation (Svenson
et al., 2011; Huzen et al., 2014). The issue is far from settled, though, and there have not
been systematic attempts to distinguish fluctuation in true dynamics from measurement
error in longitudinal data. However, given the uncertainty about the extent of individual
consistency, it does seem somewhat restrictive to base a test on the assumption that the
individual consistency is perfect. Indeed, what attracts researchers to telomere length as a
biomarker is precisely that the rate of attrition seems to vary in relation to life events (Epel
et al., 2004; Shalev, 2012; Asghar et al., 2015; Bateson, 2016). Thus, the interpretation of a
non-significant result from the Simons, Stulp & Nakagawa (2014) test, even in a very large
sample, should be cautious.
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Although we argue that the proposed test is likely to suffer from low power, we do not
have a simple correction or an alternative test to propose. This is because basic questions
about the nature of telomere dynamics over time remain unanswered, and answers to these
questions are required in order to ground any test in appropriate assumptions. The most
relevant question in the current context is whether there is individual consistency in the
rate of telomere shortening; and if, so, whether this arises from consistent environmental
influences, developmental factors, or genetic variation. Telomere dynamics are likely to
vary between species, and so different models of how telomeres change may be appropriate
to different systems. Our simulations with moderate but imperfect individual consistency
generated the consistency through an autoregressive process of order one; this is not the
only possible method, and may not be the most appropriate. Thus, we would appeal to the
field to conduct large longitudinal studies with more than two measurement time points.
As well as shedding light on the appropriateness of Simons, Stulp & Nakagawa’s (2014)
true-constant-rate assumption, this would help us to build better process models of how
telomeres change, and hence to derive robust statistical models against which empirical
data can be compared.
APPENDIX
For each individual in each dataset, baseline telomere length in base pairs is generated by:
lengthb∼N (7000,700) (1)
Length at the first follow-up year is then generated by:
length1= lengthb−attrition1 (2)
attrition1∼N (30,50) (3)
For all subsequent years:
lengthy+1= lengthy−attritiony+1 (4)
attritiony+1= r ·attritiony+
√
(1− r2)N
(
(1− r)√
(1− r2)30,50
)
(5)
Equation (5) generates attrition values that have the required level of autocorrelation r,
whilst maintaining a mean attrition of 30 bp and a standard deviation of attrition of 50 bp
(for proof see Bateson & Nettle, 2017).
Finally, measurement error is added to all telomere lengths using:
measuredy ∼N
(
lengthy ,SDe
)
(6)
Here, SDe represents the magnitude of measurement error, taken as either 0 bp, 140 bp
or 560 bp, as specified.
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